Future Indications

Harness the Power of RNA biomarkers

Caldera sees an opportunity to harness the great power of RNA biomarkers and our expertise in this area by developing specific devices/techniques that capture specific cell or vesicle types from non-invasive samples to which RNA signatures can be applied.

Our Patented Discovery Method

Our patented discovery method will be used to identify gene signatures in new indications such as:

  • Companion diagnostics to aid therapy selection and to monitor drug efficacy and resistance (personalised therapy)
  • Other cancers/conditions

Connect with us

Caldera welcomes discussions with potential collaborators, partners, patients and with clinicians. Please get in touch!

Contact us